Literature DB >> 15474671

The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer.

Antonio E Martin-Ucar1, David A Waller, Jane L Atkins, Daniel Swinson, Ken J O'Byrne, Mick D Peake.   

Abstract

We aimed to evaluate the effect of the appointment of a dedicated specialist thoracic surgeon on surgical practice for lung cancer previously served by cardio-thoracic surgeons. Outcomes were compared for the 240 patients undergoing surgical resection for lung cancer in two distinct 3-year periods: Group A: 65 patients, 1994-1996 (pre-specialist); Group B: 175 patients, 1997-1999 (post-specialist). The changes implemented resulted in a significant increase in resection rate (from 12.2 to 23.4%, P < 0.001), operations in the elderly (over 75 years) and extended resections. There were no significant differences in stage distribution, in-hospital mortality or stage-specific survival after surgery. Lung cancer surgery provided by specialists within a multidisciplinary team resulted in increased surgical resection rates without compromising outcome. Our results strengthen the case for disease-specific specialists in the treatment of lung cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15474671     DOI: 10.1016/j.lungcan.2004.03.010

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  19 in total

1.  Hospital volume and surgical outcomes of lung cancer in Japan.

Authors:  Hiroaki Osada; Etsuko Yamakoshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-09

2.  [Minimum quantities from a thoracic surgical standpoint].

Authors:  D Kaiser
Journal:  Chirurg       Date:  2007-11       Impact factor: 0.955

3.  Multidisciplinary teams in thoracic oncology-from tragic to strategic.

Authors:  Krishnamachar Harish; Agrahara Sreenivasa Kirthi Koushik
Journal:  Ann Transl Med       Date:  2015-05

Review 4.  Surgery for NSCLC in the era of personalized medicine.

Authors:  Tetsuya Mitsudomi; Kenichi Suda; Yasushi Yatabe
Journal:  Nat Rev Clin Oncol       Date:  2013-02-26       Impact factor: 66.675

Review 5.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

6.  Indication for VATS sublobar resections in early lung cancer.

Authors:  Antonio E Martin-Ucar; Maria Delgado Roel
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

7.  Improved management of acute gallstone disease after regional surgical subspecialization.

Authors:  D J Simpson; A M Wood; H M Paterson; S J Nixon; S Paterson-Brown
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

8.  Is the initial feasibility of lobectomy for stage I non-small cell lung cancer in severe heterogeneous emphysema justified by long-term survival?

Authors:  Antonio E Martin-Ucar; Khaleel R Fareed; Apostolos Nakas; Paul Vaughan; John G Edwards; David A Waller
Journal:  Thorax       Date:  2007-02-08       Impact factor: 9.139

9.  Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics.

Authors:  Rosalind Raine; Wun Wong; Shaun Scholes; Charlotte Ashton; Austin Obichere; Gareth Ambler
Journal:  BMJ       Date:  2010-01-14

10.  The size of the prize for earlier diagnosis of cancer in England.

Authors:  M A Richards
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.